Tuberculosis is still the world’s leading infectious disease killer, and one of the biggest challenges in developing new treatments is that early testing does not always reflect what happens in the human body. Scientists at Trudeau Institute are working to close that gap. In a study published in the February 2026 issue of “Infection and Immunity,” a research team led by Principal Investigator Dr. Brian Weinrick, describes improved research mod…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.